Home
US$ 28.37
kentucky glp-1 gastrointestinal obstruction attorney Ozempic Lawsuit glp-1 gastric intestinal obstruction law
Description
Berberine (BBR) exhibits significant anti-diabetic effects by enhancing insulin sensitivity, promoting glycolysis, and inhibiting gluconeogenesis
Third-party tested.
According to allegations raised in an Ozempic lawsuit filed against Novo Nordisk, side effects of the diabetes drug caused the plaintiffs intestines to fail to contract, resulting in the need for hospitalization and permanent injuries.
NEJS
